Navigation Links
Hospital team significantly reduced risk of further vascular events after 'mini strokes'
Date:10/27/2011

break up blood clots in the case of recurrent stroke. The other patients were seen in the outpatients department within three days of referral.

All the patients seen by the team received acute treatment with antithrombotic and cholesterol lowering drugs and were offered fast-track surgery if they had carotid stenosis. Follow-up included nurse-conducted health counselling after seven, 90 and 365 days. Each contact included the importance of secondary prevention, such as drug compliance and stopping smoking.

Key findings of the study included:

  • Just under two-thirds of the patients were admitted immediately after their TIA (65%) with the rest being seen as outpatients. Inpatient stays averaged one day.
  • Over half (58%) were seen within 24 hours of their TIA and 70% within 24 hours of the call for attention. The figures at one week were 76% and 89% respectively.
  • Just over 5% had a stroke, non-fatal heart attack or died from a vascular event within a year of their TIA.
  • The cumulated stroke risk was calculated and compared with the ABCD2 score, an established method of identifying individuals with a high early risk of stroke after a TIA. The actual scores in the Aarhus study were 1.6% and 2% after seven and 90 days, significantly lower than the ABCD2 predicted stroke scores of 4.5% and 7.5%.
  • Early surgery to remove the build up of plaque in the carotid blood vessels was performed in 8.5% of patients. However, the authors believe this only played a minor role in the reduced risk.
  • The majority of the patients (95%) fulfilled at least one secondary prevention measure: reduced blood pressure, reduced cholesterol, no smoking and self-reported adherence to antithrombotic treatment. 48% achieved three out of the four targets.
  • Most of the patients (93%) adhered to their antithrombotic treatment.
  • More than 60% of the patients who smoked at the time of their TIA changed their smoking habits - 31% quit
    '/>"/>

Contact: Annette Whibley
annette.wizard@gmail.com
Wiley-Blackwell
Source:Eurekalert

Page: 1 2 3

Related medicine news :

1. Thomas Jefferson University Hospital cuts Whipple procedure wound infections in half with new measures
2. Drug-Resistant Infections in Hospitals May Be Less Deadly Than Thought
3. Henry Ford Hospital first in United States to offer MKTP surgery as treatment option for vitiligo
4. NIPPV linked to increased hospital mortality rates in small group of patients
5. Hospital Programs to Reduce Antibiotic Resistance Working: Studies
6. Hospital patients suffer in shift shuffle
7. Thomas Jefferson University Hospital adopts new imaging agent to improve detection of bladder cancer
8. Fewer Patients Hospitalized for Heart Failure, U.S. Study Finds
9. Miriam Hospital researchers pilot new acute hepatitis C screening strategy for HIV-infected patients
10. Report Tracks Patient Outcomes at 5,000 U.S. Hospitals
11. Sledding injuries: a significant cause of hospitalizations, injuries during winter months
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/26/2015)... San Francisco, CA (PRWEB) February 26, 2015 ... at the American College of Traditional Chinese Medicine (ACTCM). ... March, starting off with the Chinese New Year celebration ... The event schedule is as follows: , Sunday, March ... – 2:30 p.m., ACTCM celebrates the Chinese New Year ...
(Date:2/26/2015)... 2015 β€œIn the last few years, ... evolution of one of the newest hair restoration technologies ... offers a machinery that facilitates the extraction of ... scalp,” said Dr. Parsa Mohebi. , Although ARTAS had ... at which the device extracted these grafts could not ...
(Date:2/26/2015)... Thousands of people in local communities nationwide ... for the Muscular Dystrophy Association during the 2015 MDA ... that will help save and improve the lives of ... Walk events unite and rally communities to raise funds ... are compromised β€” including everyday abilities like walking, running, ...
(Date:2/26/2015)... The COR HEALTH division of Vets Access, LLC, ... offer customers a full line of Topricin® pain relief ... effectively address muscle, joint, and nerve pain. COR ... Montrose, MI, that is dedicated to providing natural, safe ... a research and development leader in topical natural biomedicines ...
(Date:2/26/2015)... February 26, 2015 A Beautiful Smile ... practice is offering the following 50 year celebration specials ... their choice of Sonic Care Diamond Clean or the ... respectively). The cost is $2895 for the Invisalign ... more than ten treatment procedures are priced accordingly). ...
Breaking Medicine News(10 mins):Health News:ACTCM Announces March Schedule of Events 2Health News:Newest Technology now Available at Parsa Mohebi Hair Restoration 2Health News:MDA Kicks-Off Annual Muscle Walk Season in Local Communities Nationwide to Fight Back Against Muscle Disease 2Health News:MDA Kicks-Off Annual Muscle Walk Season in Local Communities Nationwide to Fight Back Against Muscle Disease 3Health News:COR HEALTH Division of Vets Access Partners with Topical BioMedics to Provide Natural Pain Relief Products 2Health News:COR HEALTH Division of Vets Access Partners with Topical BioMedics to Provide Natural Pain Relief Products 3Health News:A Beautiful Smile Dentistry is Celebrating 50 Years in Practice! 2Health News:A Beautiful Smile Dentistry is Celebrating 50 Years in Practice! 3
... of its kind, 161 postnatal women with no previous ... test the effect of a physiotherapist-led exercise and education ... an eight-week "Mother and Baby" program, including specialized exercises ... education. In the second group, "Education Only" ...
... University of Delaware have developed a new method for ... other diseases., Developed by Zhihao Zhuang, UD assistant professor ... chemical method yields hundredsfold more ubiquitylated proteins than current ... such mysteries as how cancer cells gain resistance to ...
... ... new web based clinical Label Approval System - LAS a unique workflow-based label approval ... ... the launch of their new web based clinical Label Approval System - LAS a ...
... , This release is available in ... Traditional Chinese acupuncture (TCA), where very thin ... the body to elicit beneficial therapeutic responses, may ... suffer from persistent post- viral olfactory dysfunction (PVOD), ...
... of poverty and unemployment rates that are nearly double ... Oregon tend to make less use of public assistance, ... University,s Family Policy Program. OSU researchers Deana Grobe ... University of Minnesota, found that the rates of use ...
... Mich. More than one in four elderly Americans lacked the ... of life, according to a study of 3,746 people to be ... . Those who had advance directives - including living wills ... they wanted most of the time, says lead author Maria Silveira, ...
Cached Medicine News:Health News:New mums beat the blues and increase wellbeing with physio exercise, study reveals 2Health News:UD team develops new method for producing proteins critical to medical research 2Health News:Almac to Improve Label Approval Process in Clinical Trials 2Health News:Almac to Improve Label Approval Process in Clinical Trials 3Health News:Acupuncture may be an effective treatment for post-viral infection loss of smell 2Health News:Despite much-higher poverty rates, rural Oregonians use less public assistance 2Health News:Despite much-higher poverty rates, rural Oregonians use less public assistance 3Health News:More than one-quarter of elderly patients lack decision-making capacity at death 2Health News:More than one-quarter of elderly patients lack decision-making capacity at death 3
(Date:2/26/2015)... February 26, 2015 ABIVAX, a clinical ... vaccines, today announced that it has dosed in ... IIb/III clinical trial of ABX203 which is taking place in ... The study is designed to assess whether ABX203 can deliver ... (CHB) via controlling viral load for a much longer period ...
(Date:2/26/2015)... 2015   HeartWare International, Inc . (NASDAQ: ... miniaturized circulatory support technologies that are revolutionizing the treatment ... million for the fourth quarter ended December 31, 2014, ... for the same period of 2013.  For the fiscal ... a 34% increase compared to revenue of $207.9 million ...
(Date:2/26/2015)... 26, 2015  Caris Life Sciences® today announced ... Genitourinary Cancers Symposium in Orlando, Fla. ... the Audio Poster Tour. Both studies utilized Caris ... service. These studies showed that panomic testing can ... carcinomas (RCC), providing insights that may drive selection ...
Breaking Medicine Technology:ABIVAX Recruits First Patient in a Pivotal Phase IIb/III Clinical Trial with ABX203, a Novel Immunotherapy Against Chronic Hepatitis B 2ABIVAX Recruits First Patient in a Pivotal Phase IIb/III Clinical Trial with ABX203, a Novel Immunotherapy Against Chronic Hepatitis B 3ABIVAX Recruits First Patient in a Pivotal Phase IIb/III Clinical Trial with ABX203, a Novel Immunotherapy Against Chronic Hepatitis B 4ABIVAX Recruits First Patient in a Pivotal Phase IIb/III Clinical Trial with ABX203, a Novel Immunotherapy Against Chronic Hepatitis B 5HeartWare International Reports $73.2 Million In Fourth Quarter 2014 Revenue; 38% Increase From Fourth Quarter 2013 2HeartWare International Reports $73.2 Million In Fourth Quarter 2014 Revenue; 38% Increase From Fourth Quarter 2013 3HeartWare International Reports $73.2 Million In Fourth Quarter 2014 Revenue; 38% Increase From Fourth Quarter 2013 4HeartWare International Reports $73.2 Million In Fourth Quarter 2014 Revenue; 38% Increase From Fourth Quarter 2013 5HeartWare International Reports $73.2 Million In Fourth Quarter 2014 Revenue; 38% Increase From Fourth Quarter 2013 6HeartWare International Reports $73.2 Million In Fourth Quarter 2014 Revenue; 38% Increase From Fourth Quarter 2013 7HeartWare International Reports $73.2 Million In Fourth Quarter 2014 Revenue; 38% Increase From Fourth Quarter 2013 8HeartWare International Reports $73.2 Million In Fourth Quarter 2014 Revenue; 38% Increase From Fourth Quarter 2013 9HeartWare International Reports $73.2 Million In Fourth Quarter 2014 Revenue; 38% Increase From Fourth Quarter 2013 10HeartWare International Reports $73.2 Million In Fourth Quarter 2014 Revenue; 38% Increase From Fourth Quarter 2013 11HeartWare International Reports $73.2 Million In Fourth Quarter 2014 Revenue; 38% Increase From Fourth Quarter 2013 12Caris Life Sciences' Multiplatform Tumor Profiling Helps to Identify Potential Predictive Biomarkers in Renal Cell Carcinoma 2Caris Life Sciences' Multiplatform Tumor Profiling Helps to Identify Potential Predictive Biomarkers in Renal Cell Carcinoma 3Caris Life Sciences' Multiplatform Tumor Profiling Helps to Identify Potential Predictive Biomarkers in Renal Cell Carcinoma 4Caris Life Sciences' Multiplatform Tumor Profiling Helps to Identify Potential Predictive Biomarkers in Renal Cell Carcinoma 5
... DATA ), a technology and services company focused ... reported its,operating results for the first quarter of 2008., ... revenue decreased,approximately 41% to $2,088,000 and the Company reported ... both a basic and diluted basis. These,results compared with ...
... data support potential of asenapine in the treatment of ... schizophrenia and bipolar I ... ) today announced that an overview of asenapine clinical trials,from ... of the,American Psychiatric Association in Washington, D.C., May 3-8. Data ...
Cached Medicine Technology:DATATRAK International Reports First Quarter Results for 2008 2DATATRAK International Reports First Quarter Results for 2008 3DATATRAK International Reports First Quarter Results for 2008 4DATATRAK International Reports First Quarter Results for 2008 5DATATRAK International Reports First Quarter Results for 2008 6DATATRAK International Reports First Quarter Results for 2008 7Overview of Asenapine Data from Olympia Trial Program Presented at American Psychiatric Association Annual Meeting 2Overview of Asenapine Data from Olympia Trial Program Presented at American Psychiatric Association Annual Meeting 3Overview of Asenapine Data from Olympia Trial Program Presented at American Psychiatric Association Annual Meeting 4Overview of Asenapine Data from Olympia Trial Program Presented at American Psychiatric Association Annual Meeting 5Overview of Asenapine Data from Olympia Trial Program Presented at American Psychiatric Association Annual Meeting 6Overview of Asenapine Data from Olympia Trial Program Presented at American Psychiatric Association Annual Meeting 7
Self retaining brain retractor....
The Budde Halo brain retractor is designed for use in all intercranial procedures where retraction of delicate brain tissue is required....
Langenbeck periosteal elevators, wide, blade width 11/16" (17 mm), length 7 1/2" (191 mm)....
Cushing periosteal elevators, Gutsch handle, sharp, narrow, blade width 3/16" (5 mm), length 7 5/8" (194 mm)....
Medicine Products: